$5.5M in support from Snow Medical to CREID & APPRISE for COVID-19 research
The Snow Medical Research Foundation (Snow Medical) is providing $5.5 million in funding to CREID and our partner CRE APPRISE for priority COVID-19 research projects. These projects target the critical answers we need as a nation to return to work quickly and safely, and to rebuild our economy.
CREID Director, Prof Tania Sorrell said: “Critically, the vision of Snow Medical has enabled CREID and APPRISE to leverage the joint power of their national research networks in the fight against COVID-19.”
Funding will be deployed to these four priority projects:
1. State-of-the-art data science and imaging analysis using artificial intelligence and machine learning to build a secure, national electronic data analytics platform, led by Prof Tom Snelling from the University of Sydney
2. Faster, more accurate national tracking of the spread of COVID-19. This will provide greater detail about COVID-19 infection within the Australian community. This project is led by Prof Kristine Macartney from the National Centre for Immunisation Research and Surveillance
3. A national biobank of highly characterised samples from symptomatic and asymptomatic COVID-19 positive individuals, jointly led by a national consortium of researchers from the University of Melbourne, UNSW and The University of Sydney
4. Blood and genetic markers of COVID-19 to accurately measure illness severity and predict the risk of becoming seriously ill, led by Associate Professor Benjamin Tang from Westmead Institute of Medical Research.